I would love to hear that… that our efficacy and safety
I would love to hear that… that our efficacy and safety are above all others for NAFLD/NASH. That a new big Pharma partner has taken the reigns and will finish the phase 3 trial by ourself with just Leronlimab or even with another complimentary drug to progress the results. I am not sure the FDA would allow a phase 3 with an additional drug added at this point in trials and might reset the progress to regress to a phase two for safety only… to be proven first.
That’s the concern going forward. Adding another drug could take away our so far unblemished safety record that we think we have. Soon we will know if that’s true with the aggregated assessed safety look at our overall 20 trials to date. It will be interesting to see what we have been told all along that there has never been a safety issue of any kind with Leronlimab. This is what we hope to be proven true and recognition by those in power to reinstate our trials and progress our move out of the proverbial dog house into safety territory with only great results in NAFLD/NASH and mTNBC and HIV. Having the non-toxic label and safer than placebo will suit us very good going forward in all trials. As one former promoter once said… “safer than saline water.” This would be a great assessment. We can only hope it works this way.
Am I the only one sitting on pins and needles waiting for the news to break at the June 25th Nash conference? Hoping for nothing but great days once the release of information we all know should be better that the 350mg open trial. Watching the climb upward of the stock price like it once did.
It’s tougher every day waiting for me. At least… I am not getting up in the middle of the night looking for news at 3am like I use to.. being on the west coast. It was nice to know that in order to be in the conference you could not announce your trial results prior to the conference. That is allowing me some good sleep lately. Knowing when the news should be revealed is everything.
I still can’t wait… damn it!
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...
Continue Reading
What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...
Continue Reading
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...
Continue Reading
New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...
Continue Reading
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...
Continue Reading
Top 5 Most Recently Viewed Articles
Latest Developments Impacting Spirit Airlines (SAVE) Stock Performance Spirit Airlines Inc (SAVE) has experienced notable stock market fluctuations recently, especially after announcing a significant transaction that has captured investor interest. Last week, the budget airline revealed in an SEC filing that it had engaged with GA Telesis to sell 23 A320ceo/A321ceo...
Continue Reading
Inquiry into 23andMe Holding Co. Barrack, Rodos & Bacine has launched an investigation into recent governance changes at 23andMe Holding Co. Their primary focus is the mass resignation of all independent board members, which occurred following CEO Anne Wojcicki's controversial proposal to buy out remaining shares for just 40 cents each. Background of the Situation The CEO...
Continue Reading
Revyve Attracts Significant Investment for Sustainable Protein Dutch food-tech company Revyve has successfully raised nearly €24 million in its latest funding round, which is set to significantly boost its production of yeast proteins aimed at replacing eggs in various food applications. The total capital raised by Revyve now exceeds €40 million, reflecting a robust...
Continue Reading
India Seeks Vital Partnership in Critical Minerals with US India is making significant strides towards securing a critical minerals partnership agreement with the United States. This ambition was highlighted by Piyush Goyal, the country's trade minister, who announced hopes for expanded discussions on a more comprehensive trade pact. Intent Behind the Agreement During a...
Continue Reading
Experience the Thrill of Copy Trading with Toobit In an exciting move, Toobit, a leading player in the world of cryptocurrency exchanges, has launched its Copy Trading Festival. Designed to provide a generous reward pool of 100,000 USDT, this autumn event is an invitation for traders both new and experienced to embark on an enriching trading journey. Why You Should...
Continue Reading
